PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för ceftolozane. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

9 hits

Bibliografisk träff 2018-03-09

Ceftolozane/tazobactam: place in therapy.

Giacobbe DR, Bassetti M, De Rosa FG, Del Bono V, Grossi PA, Menichetti F, Pea F, Rossolini GM, Tumbarello M, Viale P, Viscoli C, ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva).

Expert Rev Anti Infect Ther · research support, non-u.s. gov't; review; journal article · DOI 10.1080/14787210.2018.1447381

Bibliografisk träff 2018-03-08

Safety, Tolerability, and Pharmacokinetics of 3 g of Ceftolozane/Tazobactam in Healthy Adults: A Randomized, Placebo-Controlled, Multiple-Dose Study.

Yu B, Adedoyin A, Hershberger E, Caro L, Xiao A, Rhee EG, Huntington JA.

Clin Pharmacol Drug Dev · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1002/cpdd.429

Bibliografisk träff 2018-01-24

Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa.

Shields RK, Clancy CJ, Pasculle AW, Press EG, Haidar G, Hao B, Chen L, Kreiswirth BN, Nguyen MH.

J Clin Microbiol · comparative study; research-article; evaluation study; journal article; research support, n.i.h., extramural · DOI 10.1128/jcm.01093-17

Bibliografisk träff 2018-01-01

Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Novel Therapy for Multidrug Resistant Gram Negative Infections in Children.

Rodriguez BA, Girotto JE, Nicolau DP.

Curr Pediatr Rev · review; journal article · DOI 10.2174/1573396314666180308150908

Bibliografisk träff 2017-11-22

<i>In Vitro</i> Comparison of Ceftolozane-Tazobactam to Traditional Beta-Lactams and Ceftolozane-Tazobactam as an Alternative to Combination Antimicrobial Therapy for Pseudomonas aeruginosa.

Goodlet KJ, Nicolau DP, Nailor MD.

Antimicrob Agents Chemother · research-article; multicenter study; journal article · DOI 10.1128/aac.01350-17

Bibliografisk träff 2017-11-22

Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates.

Humphries RM, Hindler JA, Wong-Beringer A, Miller SA.

Antimicrob Agents Chemother · brief-report; multicenter study; journal article · DOI 10.1128/aac.01858-17

Bibliografisk träff 2017-10-07

Cross-reactivity in β-Lactam Allergy.

Zagursky RJ, Pichichero ME.

J Allergy Clin Immunol Pract · review; journal article · DOI 10.1016/j.jaip.2017.08.027

Bibliografisk träff 2017-10-05

Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam.

Xipell M, Bodro M, Marco F, Martínez JA, Soriano A.

Future Microbiol · journal article; case reports · DOI 10.2217/fmb-2017-0018

Bibliografisk träff 2017-07-06

In vitro activity of ceftolozane/tazobactam in combination with other classes of antibacterial agents.

Jacqueline C, Howland K, Chesnel L.

J Glob Antimicrob Resist · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jgar.2017.04.003